Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BeOne Medicines AGADR(ONC) | 10,568,897 | 10,568,897 | 0 | $1.51B | $2.37B | 24.59% | +$864.96M |
| Incyte Corporation(INCY) | 30,738,524 | 30,739,020 | +496 | $1.86B | $2.03B | 21.06% | +$168.48M |
| ACADIA Pharmaceuticals Inc. | 42,877,916 | 42,877,916 | 0 | $696.77M | $659.46M | 6.83% | -$37.30M |
| Summit Therapeutics Inc.(SMMT) | 23,222,222 | 24,424,865 | +1,202,643 | $181.13M | $534.90M | 5.54% | +$353.77M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,974,590 | 1,974,590 | 0 | $553.20M | $419.05M | 4.34% | -$134.15M |
| Revolution Medicines, Inc.(RVMD) | 7,569,090 | 7,569,090 | 0 | $293.76M | $343.26M | 3.56% | +$49.50M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 6,398,365 | 6,398,366 | +1 | $262.72M | $335.21M | 3.47% | +$72.49M |
| Insmed Incorporated(INSM) | 3,576,038 | 4,415,918 | +839,880 | $239.59M | $322.36M | 3.34% | +$82.77M |
| Kymera Therapeutics, Inc.(KYMR) | 5,995,928 | 5,995,929 | +1 | $178.98M | $283.79M | 2.94% | +$104.81M |
| Bicycle Therapeutics plcADS | 9,399,960 | 9,399,960 | 0 | $190.26M | $212.72M | 2.20% | +$22.47M |
| Edgewise Therapeutics, Inc.(EWTX) | 5,840,059 | 5,840,059 | 0 | $105.18M | $155.87M | 1.62% | +$50.69M |
| Replimune Group, Inc.(REPL) | 10,045,336 | 11,045,336 | +1,000,000 | $90.41M | $121.06M | 1.25% | +$30.65M |
| Alkermes plcSHS(ALKS) | 4,181,751 | 4,181,751 | 0 | $100.78M | $117.05M | 1.21% | +$16.27M |
| Denali Therapeutics Inc.(DNLI) | 3,731,695 | 3,731,695 | 0 | $86.65M | $108.70M | 1.13% | +$22.05M |
| Insmed IncorporatedNOTE 0 75 6 1 2028(INSM) | 0 | 0 | 0 | $90.41M | $98.33M | 1.02% | +$7.91M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 1,466,547 | 1,576,114 | +109,567 | $60.28M | $87.55M | 0.91% | +$27.28M |
| Nurix Therapeutics, Inc.(NRIX) | 3,882,125 | 3,882,125 | 0 | $81.02M | $87.23M | 0.90% | +$6.21M |
| Entrada Therapeutics, Inc.(TRDA) | 4,865,819 | 4,865,819 | 0 | $69.34M | $77.76M | 0.81% | +$8.42M |
| Immatics N.V.SHS(IMTX) | 6,443,398 | 6,443,398 | 0 | $74.87M | $73.52M | 0.76% | -$1.35M |
| AbCellera Biologics Inc.(ABCL) | 27,525,640 | 27,525,640 | 0 | $81.48M | $71.57M | 0.74% | -$9.91M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 2,818,323 | 2,818,323 | 0 | $52.62M | $70.43M | 0.73% | +$17.81M |
| IGM Biosciences, Inc. | 4,090,316 | 4,092,310 | +1,994 | $28.10M | $67.69M | 0.70% | +$39.59M |
| argenx SEADR(ARGX) | 111,904 | 111,904 | 0 | $48.12M | $60.66M | 0.63% | +$12.54M |
| Stoke Therapeutics, Inc.(STOK) | 4,368,443 | 4,368,443 | 0 | $59.02M | $53.69M | 0.56% | -$5.33M |
| Immunocore Holdings plcADS(IMCR) | 1,515,318 | 1,515,318 | 0 | $51.35M | $47.17M | 0.49% | -$4.18M |
| Kodiak Sciences Inc.(KOD) | 17,310,490 | 17,310,490 | 0 | $40.68M | $45.18M | 0.47% | +$4.50M |
| Sera Prognostics, Inc.CL A(SERA) | 5,434,399 | 5,434,399 | 0 | $32.17M | $42.39M | 0.44% | +$10.22M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 100,000 | 843,075 | +743,075 | $5.40M | $39.61M | 0.41% | +$34.21M |
| Xenon Pharmaceuticals Inc.(XENE) | 993,679 | 993,679 | 0 | $38.74M | $39.12M | 0.41% | +$377.6K |
| Immunovant, Inc.(IMVT) | 464,718 | 1,225,410 | +760,692 | $12.27M | $34.94M | 0.36% | +$22.67M |
| Cerus Corporation(CERS) | 19,477,339 | 19,477,339 | 0 | $34.28M | $33.89M | 0.35% | -$389.5K |
| IDEAYA Biosciences, Inc.(IDYA) | 1,062,123 | 1,062,123 | 0 | $37.29M | $33.65M | 0.35% | -$3.64M |
| Roivant Sciences Ltd.SHS(ROIV) | 2,798,716 | 2,798,716 | 0 | $29.58M | $32.30M | 0.33% | +$2.71M |
| Akero Therapeutics, Inc. | 1,097,082 | 1,097,082 | 0 | $25.74M | $31.48M | 0.33% | +$5.74M |
| Krystal Biotech, Inc.(KRYS) | 169,934 | 169,934 | 0 | $31.21M | $30.93M | 0.32% | -$273.6K |
| Celcuity Inc.(CELC) | 1,874,978 | 1,874,978 | 0 | $30.71M | $27.96M | 0.29% | -$2.76M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 4,916,095 | 4,916,095 | 0 | $18.39M | $26.06M | 0.27% | +$7.67M |
| Dyne Therapeutics, Inc.(DYN) | 672,096 | 672,096 | 0 | $23.72M | $24.14M | 0.25% | +$423.4K |
| Biomea Fusion, Inc.(BMEA) | 2,108,949 | 2,108,949 | 0 | $9.49M | $21.30M | 0.22% | +$11.81M |
| Bicara Therapeutics Inc. | 0 | 833,333 | +833,333 | $0 | $21.22M | 0.22% | +$21.22M |
| Prelude Therapeutics Incorporated(PRLD) | 10,123,824 | 10,123,824 | 0 | $38.57M | $20.96M | 0.22% | -$17.62M |
| Centessa Pharmaceuticals plcADS | 549,212 | 1,227,178 | +677,966 | $4.96M | $19.62M | 0.20% | +$14.66M |
| Neurogene Inc.(NGNE) | 456,015 | 456,015 | 0 | $16.59M | $19.13M | 0.20% | +$2.54M |
| Praxis Precision Medicines, Inc.(PRAX) | 131,533 | 323,105 | +191,572 | $5.44M | $18.59M | 0.19% | +$13.15M |
| Alumis Inc. | 1,562,500 | 1,562,500 | 0 | $20.78M | $16.69M | 0.17% | -$4.09M |
| Merus N.V. | 300,000 | 300,000 | 0 | $17.75M | $14.99M | 0.16% | -$2.76M |
| TScan Therapeutics, Inc.(TCRX) | 2,784,792 | 2,784,792 | 0 | $16.29M | $13.87M | 0.14% | -$2.42M |
| Neumora Therapeutics, Inc.(NMRA) | 1,034,600 | 1,034,600 | 0 | $10.17M | $13.67M | 0.14% | +$3.50M |
| Xencor, Inc.(XNCR) | 545,431 | 670,431 | +125,000 | $10.33M | $13.48M | 0.14% | +$3.16M |
| 2seventy bio, Inc. | 2,497,526 | 2,497,526 | 0 | $9.62M | $11.79M | 0.12% | +$2.17M |
| Fate Therapeutics, Inc.(FATE) | 2,997,772 | 2,997,772 | 0 | $9.83M | $10.49M | 0.11% | +$659.5K |
| Arvinas, Inc.(ARVN) | 0 | 405,576 | +405,576 | $0 | $9.99M | 0.10% | +$9.99M |
| Sana Biotechnology, Inc.(SANA) | 2,380,949 | 2,380,949 | 0 | $13.00M | $9.90M | 0.10% | -$3.10M |
| Design Therapeutics, Inc.(DSGN) | 1,695,294 | 1,743,725 | +48,431 | $5.68M | $9.38M | 0.10% | +$3.70M |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 223,470 | +223,470 | $0 | $8.95M | 0.09% | +$8.95M |
| Ceryvyn Therapeutics LimitedADS(CKDXF) | 2,173,622 | 2,173,622 | 0 | $4.20M | $8.85M | 0.09% | +$4.65M |
| Celldex Therapeutics, Inc.(CLDX) | 247,644 | 247,644 | 0 | $9.17M | $8.42M | 0.09% | -$747.9K |
| Relay Therapeutics, Inc.(RLAY) | 1,160,117 | 1,160,117 | 0 | $7.56M | $8.21M | 0.09% | +$649.7K |
| Verve Therapeutics, Inc. | 1,691,530 | 1,691,530 | 0 | $8.25M | $8.19M | 0.08% | -$67.7K |
| Taysha Gene Therapies, Inc.(TSHA) | 4,004,756 | 4,004,756 | 0 | $8.97M | $8.05M | 0.08% | -$921.1K |
| Mirum Pharmaceuticals, Inc.(MIRM) | 190,476 | 190,476 | 0 | $6.51M | $7.43M | 0.08% | +$916.2K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 312,500 | 312,500 | 0 | $5.50M | $5.98M | 0.06% | +$478.1K |
| Tango Therapeutics, Inc.(TNGX) | 750,000 | 750,000 | 0 | $6.43M | $5.78M | 0.06% | -$660.0K |
| Skye Bioscience, Inc.(SKYE) | 500,000 | 1,434,634 | +934,634 | $4.00M | $5.61M | 0.06% | +$1.60M |
| Vaxcyte, Inc.(PCVX) | 48,885 | 48,885 | 0 | $3.69M | $5.59M | 0.06% | +$1.89M |
| Crinetics Pharmaceuticals, Inc. | 103,927 | 103,927 | 0 | $4.65M | $5.31M | 0.06% | +$655.8K |
| DBV Technologies S.A.ADR | 7,307,131 | 7,307,131 | 0 | $5.85M | $5.11M | 0.05% | -$738.0K |
| KALA BIO, Inc.(KALA) | 891,335 | 891,335 | 0 | $6.32M | $5.08M | 0.05% | -$1.24M |
| Generation Bio Co. | 1,206,957 | 1,944,945 | +737,988 | $3.40M | $4.80M | 0.05% | +$1.40M |
| Alector, Inc. | 927,264 | 927,264 | 0 | $4.21M | $4.32M | 0.04% | +$111.3K |
| Prime Medicine, Inc.(PRME) | 1,028,466 | 1,028,466 | 0 | $5.29M | $3.98M | 0.04% | -$1.31M |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 1,381,898 | 1,381,898 | 0 | $4.73M | $3.83M | 0.04% | -$898.2K |
| Structure Therapeutics Inc.ADS | 0 | 85,500 | +85,500 | $0 | $3.75M | 0.04% | +$3.75M |
| Arcturus Therapeutics Holdings Inc.(ARCT) | 151,329 | 151,329 | 0 | $3.68M | $3.51M | 0.04% | -$172.5K |
| HOOKIPA Pharma Inc. | 8,128,151 | 812,814 | -7,315,337 | $4.81M | $3.50M | 0.04% | -$1.32M |
| Cypherpunk Technologies Inc.(CYPH) | 1,172,175 | 1,172,175 | 0 | $2.30M | $3.01M | 0.03% | +$715.0K |
| Enliven Therapeutics, Inc. | 114,833 | 114,833 | 0 | $2.68M | $2.93M | 0.03% | +$249.2K |
| Compass Therapeutics, Inc.(CMPX) | 1,557,630 | 1,557,630 | 0 | $1.56M | $2.87M | 0.03% | +$1.31M |
| Wave Life Sciences, Inc.SHS(WVE) | 0 | 344,063 | +344,063 | $0 | $2.82M | 0.03% | +$2.82M |
| Mersana Therapeutics, Inc. | 1,086,115 | 1,086,115 | 0 | $2.18M | $2.05M | 0.02% | -$130.3K |
| NewAmsterdam Pharma Company N.V. ORDINARY SHARES | 96,827 | 96,711 | -116 | $1.86M | $1.61M | 0.02% | -$254.6K |
| Century Therapeutics, Inc.(IPSC) | 797,460 | 797,460 | 0 | $2.03M | $1.36M | 0.01% | -$669.9K |
| vTv Therapeutics Inc.CL A(VTVT) | 97,314 | 97,314 | 0 | $1.72M | $1.32M | 0.01% | -$398.5K |
| Aerovate Therapeutics, Inc. | 628,939 | 628,939 | 0 | $1.04M | $1.31M | 0.01% | +$270.4K |
| Pfizer Inc.(PFE) | 35,000 | 35,000 | 0 | $979.3K | $1.01M | 0.01% | +$33.6K |
| Protara Therapeutics, Inc.(TARA) | 536,832 | 536,832 | 0 | $1.12M | $982.4K | 0.01% | -$134.2K |
| Aligos Therapeutics, Inc.(ALGS) | 0 | 83,055 | +83,055 | $0 | $719.3K | 0.01% | +$719.3K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 75,778 | 75,778 | 0 | $468.3K | $575.9K | 0.01% | +$107.6K |
| PMV Pharmaceuticals, Inc.(PMVP) | 322,024 | 322,024 | 0 | $521.7K | $479.8K | 0.00% | -$41.9K |
| Foghorn Therapeutics Inc.(FHTX) | 45,027 | 45,027 | 0 | $258.9K | $419.2K | 0.00% | +$160.3K |
| Acrivon Therapeutics, Inc. | 52,885 | 52,885 | 0 | $306.7K | $370.2K | 0.00% | +$63.5K |
| Tyra Biosciences, Inc.(TYRA) | 10,607 | 10,607 | 0 | $169.6K | $249.4K | 0.00% | +$79.8K |
| Surrozen, Inc.W EXP 8 11 2026(SRZN) | 833,333 | 833,333 | 0 | $13.8K | $8.6K | 0.00% | -$5.3K |
| Achilles Therapeutics plcADS | 1,108,767 | 0 | -1,108,767 | $903.6K | $0 | — | -$903.6K |
| Adaptimmune Therapeutics plcADR(ADAPY) | 2,343,695 | 0 | -2,343,695 | $2.28M | $0 | — | -$2.28M |
| Aligos Therapeutics, Inc. | 2,076,400 | 0 | -2,076,400 | $726.7K | $0 | — | -$726.7K |
| Athira Pharma, Inc. | 3,153,807 | 0 | -3,153,807 | $8.36M | $0 | — | -$8.36M |
| Cerevel Therapeutics Holdings, Inc. | 683,588 | 0 | -683,588 | $27.95M | $0 | — | -$27.95M |
| Sage Therapeutics, Inc. | 171,026 | 0 | -171,026 | $1.86M | $0 | — | -$1.86M |
| Talis Biomedical Corporation | 508,323 | 0 | -508,323 | $4.40M | $0 | — | -$4.40M |